TP53 and neoplasm: In conclusion, this study confirmed the high frequency of TP53 alterations in MFS (86.4% of cases), highlighting their potential role in driving tumor aggressiveness and reinforcing the value of molecular profiling to better define the prognostic relevance of p53 in this malignancy.